The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

To the cell biologist, however, 'endothelial cell dysfunction' may represent an alteration of an extensive gene program and changes in a host of signaling pathways and secreted factors.

The tumor microenvironment (TME) consists of a complex mix of cellular and non-cellular components, including immune cells, ...

Surrozen is a biotechnology company developing tissue-specific antibodies to selectively modulate the Wnt pathway, with a current focus on ophthalmology. Its proprietary technologies aim to harness ...

Androgen deficiency is an important cause of erectile dysfunction (ED), and miRNAs are small-molecule RNAs with multiple biological functions. However, whether androgen deficiency affects erectile ...

Bone morphogenetic protein 2 (BMP2), a key isoform within the bone morphogenetic protein family, plays a critical role in promoting angiogenesis and peripheral nerve regeneration, but its specific ...

Compass Therapeutics, Inc.’s CMPX share price has dipped by 5.62%, which has investors questioning if this is right time to buy.

Discover how nighttime wakefulness triggers DNA damage, metabolic chaos, and brain deterioration that accelerates aging and ...

Phase 3 results Tovecimig (Compass Therapeutics) Bispecific antibody that blocks Delta-like ligand 4 and vascular endothelial growth factor A signaling pathways In combination with paclitaxel to ...

Torbjörn Ogéus guides us through the evolving science of stromal vascular fraction, exosomes, and beyond in regenerative ...

A new publication shines a spotlight on HER3, a long-overlooked member of the ErbB receptor family, revealing its critical ...